Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
Authors
Keywords
Triple negative breast cancer, Small interfering RNA, Nanoparticles, Redox responsive
Journal
LIFE SCIENCES
Volume 266, Issue -, Pages 118886
Publisher
Elsevier BV
Online
2020-12-11
DOI
10.1016/j.lfs.2020.118886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy
- (2020) Yunfei Wang et al. Nanoscale Research Letters
- EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
- (2020) Xiang Song et al. Cancer Management and Research
- Cell Penetrating Peptides, Novel Vectors for Gene Therapy
- (2020) Rebecca E. Taylor et al. Pharmaceutics
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Cell penetrating peptides: the potent multi-cargo intracellular carriers
- (2019) Kimia Kardani et al. Expert Opinion on Drug Delivery
- Redox-triggered intracellular siRNA delivery
- (2018) N. Basaran Mutlu Agardan et al. CHEMICAL COMMUNICATIONS
- JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways
- (2018) Xiaojing Liu et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Targeting Brd4 for cancer therapy: inhibitors and degraders
- (2018) Yingchao Duan et al. MedChemComm
- Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities
- (2018) Vijayan Venugopal et al. PLoS One
- Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles
- (2017) Zheyong Huang et al. International Journal of Nanomedicine
- Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway
- (2017) Jiaqi Hao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PEGylation of the GALA Peptide Enhances the Lung-Targeting Activity of Nanocarriers That Contain Encapsulated siRNA
- (2017) Sarochin Santiwarangkool et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A novel guaiane sesquiterpene derivative, guai-2-en-10α-ol, from Ulva fasciata Delile inhibits EGFR/PI3K/Akt signaling and induces cytotoxicity in triple-negative breast cancer cells
- (2017) T. Pragna Lakshmi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis
- (2017) Forest H. Andrews et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth
- (2017) Hua Zhu et al. Oncotarget
- BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
- (2016) Guillaume Andrieu et al. CANCER RESEARCH
- Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy
- (2016) Hui Jing et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer
- (2016) Haifeng Qiu et al. Oncotarget
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers
- (2015) William Jacot et al. BMC CANCER
- Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer
- (2015) Olivier Trédan et al. Clinical Breast Cancer
- Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease
- (2015) Xiaoyao Zheng et al. PHARMACEUTICAL RESEARCH
- MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
- (2015) Zhuxian Zhou et al. Nature Communications
- Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
- (2015) Gong-Quan Li et al. Oncotarget
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Multimodal SPION-CREKA peptide based agents for molecular imaging of microthrombus in a rat myocardial ischemia-reperfusion model
- (2014) Yanan Song et al. BIOMATERIALS
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- A display of pH-sensitive fusogenic GALA peptide facilitates endosomal escape from a Bio-nanocapsule via an endocytic uptake pathway
- (2014) Yuya Nishimura et al. JOURNAL OF NANOBIOTECHNOLOGY
- Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma
- (2013) Eun Ji Chung et al. BIOMATERIALS
- Structural Effects and Lipid Membrane Interactions of the pH-Responsive GALA Peptide with Fatty Acid Acylation
- (2012) Brian F. Lin et al. BIOCHEMISTRY
- Targeting EGFR in Triple Negative Breast Cancer
- (2012) Naoto T. Ueno et al. Journal of Cancer
- Triple negative breast cancer - prognostic factors and survival
- (2011) Tanja Ovcaricek et al. Radiology and Oncology
- Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer
- (2010) Takeshi Yoshida et al. BIOCHEMICAL PHARMACOLOGY
- Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection
- (2010) Xuan Zeng et al. BIOMATERIALS
- Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine–hyaluronic acid conjugate
- (2010) Kitae Park et al. BIOMATERIALS
- Chemotherapy and signaling
- (2010) Tetyana V. Bagnyukova et al. CANCER BIOLOGY & THERAPY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Controlling HBV Replicationin Vivoby Intravenous Administration of Triggered PEGylated siRNA-Nanoparticles
- (2009) Sergio Carmona et al. MOLECULAR PHARMACEUTICS
- Recent advances in quantitative colocalization analysis: Focus on neuroscience
- (2009) Vadim Zinchuk et al. PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Potential chemotherapy side effects: What do oncologists tell parents?
- (2008) Lisa Ysela Ramirez et al. PEDIATRIC BLOOD & CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started